Recurrence and cancer-related mortality in patients with endocervical adenocarcinoma
| Recurrences | Deaths | ||
| HPVA (n=62 with follow-up) | Usual | 3/43 (7%) | 0/51 (0%) |
| Mucinous NOS | 1/9 (11%) | 0/9 (0%) | |
| Mucinous intestinal | 1/2 (50%) | 0/2 (0%) | |
| ISMC | 4/8 (50%) | 2/8 (25%) | |
| NHPVA (n=16 with follow-up) | Gastric | 6/12 (50%) | 5/12 (42%) |
| Clear cell | 1/2 (50%) | 1/2 (50%) | |
| Mesonephric | 1/2 (50%) | 1/2 (50%) |
HPVA, human papillomavirus–associated adenocarcinoma; ISMC, invasive stratified mucin-producing carcinoma (so-called invasive SMILE); NHPVA, non-human papillomavirus–associated adenocarcinoma; NOS, not otherwise specified.